Australia markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0800-0.0600 (-5.26%)
At close: 04:00PM EDT
1.0500 -0.03 (-2.78%)
Pre-market: 07:36AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 72.21M
Enterprise value 57.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.15
Price/book (mrq)0.87
Enterprise value/revenue 1.53
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.41
52-week change 3-84.79%
S&P500 52-week change 328.04%
52-week high 38.2000
52-week low 30.7100
50-day moving average 30.9804
200-day moving average 31.7756

Share statistics

Avg vol (3-month) 31.42M
Avg vol (10-day) 31.31M
Shares outstanding 566.86M
Implied shares outstanding 666.86M
Float 854.5M
% held by insiders 10.39%
% held by institutions 110.04%
Shares short (15 Apr 2024) 45.36M
Short ratio (15 Apr 2024) 43.29
Short % of float (15 Apr 2024) 48.77%
Short % of shares outstanding (15 Apr 2024) 48.75%
Shares short (prior month 15 Mar 2024) 45.47M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 307 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-269.97%

Management effectiveness

Return on assets (ttm)-33.39%
Return on equity (ttm)-134.56%

Income statement

Revenue (ttm)36.12M
Revenue per share (ttm)1.06
Quarterly revenue growth (yoy)30.50%
Gross profit (ttm)N/A
EBITDA -125.72M
Net income avi to common (ttm)-232.49M
Diluted EPS (ttm)-6.8100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)66.77M
Total cash per share (mrq)1.22
Total debt (mrq)79.41M
Total debt/equity (mrq)82.59%
Current ratio (mrq)1.40
Book value per share (mrq)2.10

Cash flow statement

Operating cash flow (ttm)-125.18M
Levered free cash flow (ttm)-97.73M